Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Triostat

Last reviewed on RxList: 10/16/2019
Triostat Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 10/16/2019

Triostat (liothyronine sodium injection) (T3) is a thyroid hormone preparation indicated in the treatment of myxedema coma/precoma. Triostat can be used in patients allergic to desiccated thyroid or thyroid extract derived from pork or beef. Triostat is available in generic form. Common side effects of Triostat include:

An initial intravenous Triostat dose ranging from 25 mcg to 50 mcg is recommended in the emergency treatment of myxedema coma/precoma in adults. Triostat may interact with oral anticoagulants, insulin or oral hypoglycemics, estrogen, oral contraceptives, tricyclic antidepressants, digitalis, ketamine, and vasopressors. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant before receiving Triostat. Thyroid hormones do not readily cross the placental barrier and in general, thyroid replacement therapy to hypothyroid women should not be discontinued during pregnancy. Minimal amounts of Triostat pass into breast milk. Thyroid hormones such as Triostat are not generally associated with serious side effects. Consult your doctor before breastfeeding.

Our Triostat (liothyronine sodium injection) (T3) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

QUESTION

Where is the thyroid gland located? See Answer
Triostat Professional Information

SIDE EFFECTS

The most frequently reported adverse events were arrhythmia (6% of patients) and tachycardia (3%). Cardiopulmonary arrest, hypotension and myocardial infarction occurred in approximately 2% of patients. The following events occurred in approximately 1% or fewer of patients: angina, congestive heart failure, fever, hypertension, phlebitis and twitching.

In rare instances, allergic skin reactions have been reported with liothyronine sodium tablets.

For medical advice about your adverse reactions contact your medical professional. To report SUSPECTED ADVERSE REACTIONS, contact JHP at 1-866-923-2547 or MEDWATCH at 1-800-FDA-1088 (1-800-332-1088) or http://www.fda.gov/medwatch/.

Read the entire FDA prescribing information for Triostat (Liothyronine Sodium Injection)

SLIDESHOW

Hyperthyroidism Symptoms and Treatment See Slideshow
Related Resources for Triostat

© Triostat Patient Information is supplied by Cerner Multum, Inc. and Triostat Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors